| 中國醫藥大學 |
2010-06 |
Tumor heterogeneity of Figo stage III carcinoma of the uterine cervix:In regard to Kim et al.
|
陳尚文(Shang-Wen Chen)*; 梁基安(Ji-An Liang) |
| 亞洲大學 |
2017-03 |
Tumor Hypoxia Regulates Forkhead Box C1 to Promote Lung Cancer Progression
|
Hsieh, 林佑融；Yu-Jung Lin；Woei-Cherng；Woei-Cherng Shyu；Chi-Wei Chan；Chi-Wei Chang；Chi-Chung Wa；Chi-Chung Wang；Chung-Pu Wu；Chung-Pu Wu；Hsu-Tung Lee；Hsu-Tung Lee；Liang-Jwu Ch；Liang-Jwu Chen；謝佳宏；Chia-Hung |
| 國立臺灣大學 |
1999 |
Tumor Immunology - When a Cancer Cell Meets the Immune Cells
|
許世明; HSU, SU-MING |
| 臺大學術典藏 |
2018-09-10T07:47:37Z |
Tumor immunology - When a cancer cell meets the immune cells
|
Sheu, B.-C. and Hsu, S.-M. and Ho, H.-N. and Lin, R.-H. and Huang, S.-C.; BOR-CHING SHEU |
| 臺大學術典藏 |
2018-09-10T07:48:02Z |
Tumor immunology - When a cancer cell meets the immune cells
|
Sheu, B.-C. and Hsu, S.-M. and Ho, H.-N. and Lin, R.-H. and Huang, S.-C.; HONG-NERNG HO |
| 臺大學術典藏 |
2020-01-22T06:00:39Z |
Tumor immunology - When a cancer cell meets the immune cells
|
Bor-Ching Sheu;Hsu S.-M.;Ho H.-N.;Lin R.-H.;Huang S.-C.; BOR-CHING SHEU; Hsu S.-M.; Ho H.-N.; Lin R.-H.; Huang S.-C. |
| 臺大學術典藏 |
1999 |
Tumor immunology - When a cancer cell meets the immune cells
|
Huang S.-C.; Lin R.-H; HONG-NERNG HO; Hsu S.-M; Sheu B.-C; Sheu B.-C;Hsu S.-M;Hong-Nerng Ho;Lin R.-H;Huang S.-C. |
| 國立臺灣大學 |
2016 |
TUMOR INDUCED OSTEOMALACIA IN TAIWAN
|
Tsai, K. -S.; Lee, J. -C.; Shih, S. -R.; Chili, W. -Y.; Shih, S. R.; 蔡克嵩; 李仁傑; 施翔蓉 |
| 臺北醫學大學 |
1969-06 |
Tumor Inhibitions XLII Thalidasine A Novel Bisenzylisoquinoline Alkaloid Tumor Inhibitor from Thalictru dasycarpum
|
楊藏雄 |
| 臺北醫學大學 |
1969 |
Tumor Inhibitors. XLII. Thalidasine, a Novel Bisbenzylisoquinoline Alkaloid Tumor Inhibitor from Thalictrum dasycarpum
|
S. MORRIS KUPCHAN; T. H. YANG; GEORGE S. VASILIKIOTIS; MICHAEL H. BARNES; M. L. KING |
| 國家衛生研究院 |
2001-03-15 |
Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac
|
Chen, WS; Wei, SJ; Liu, JM; Hsiao, M; Lin, JK; Yang, WK |
| 國立臺灣大學 |
1988 |
Tumor Invasiveness and Prognosis in Resected Hepatocellular Carcinoma:Clinical and Pathogenetic Implications
|
許輝吉; Wu, T. T.; Wu, M. Z.; Sheu, J. C.; Lee, C. S.; Chen, D. S.; Hsieh, F. J.; Hsu, Hwei-Chi; Wu, T. T.; Wu, M. Z.; Sheu, J. C.; Lee, C. S.; Chen, D. S.; Hsieh, F. J. |
| 國立成功大學 |
2011-11 |
Tumor length assessed by miniprobe endosonography can predict the survival of the advanced esophageal squamous cell carcinoma with stricture receiving concurrent chemoradiation
|
Chang, W-L |
| 臺大學術典藏 |
2021-01-26T03:36:41Z |
Tumor location on MRI determines outcomes of patients with prostate cancer after total prostate cryoablation
|
Chung-Hsin Chen;Chen Y.-C.;Pu Y.-S.; CHUNG-HSIN CHEN; Chen Y.-C.; Pu Y.-S. |
| 臺大學術典藏 |
2021-02-02T00:45:56Z |
Tumor location on MRI determines outcomes of patients with prostate cancer after total prostate cryoablation
|
Chen C.-H.;Chen Y.-C.;Yeong-Shiau Pu; Chen C.-H.; Chen Y.-C.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-03-02T14:00:17Z |
Tumor location on MRI determines outcomes of patients with prostate cancer after total prostate cryoablation
|
CHUNG-HSIN CHEN; Chen, Yu Ching; YEONG-SHIAU PU |
| 國立臺灣大學 |
2012 |
Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma
|
Tsai, Wan-Ling; Liang, Po-Chin; Chen, Chien-Hung; 陳健弘; 梁博欽 |
| 臺大學術典藏 |
2018-09-10T09:15:18Z |
Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma
|
Tsai, Wan-Ling;Liang, Po-Chin;Chen, Chien-Hung; Tsai, W.-L. and Liang, P.-C. and Chen, C.-H.; 陳健弘 ;梁博欽; Tsai, Wan-Ling; PO-CHIN LIANG; Liang, Po-Chin; Chen, Chien-Hung |
| 臺大學術典藏 |
2020-08-11T08:36:52Z |
Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma
|
Tsai W.-L.; PO-CHIN LIANG; Chen C.-H. |
| 臺大學術典藏 |
2022-02-22T05:34:20Z |
Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma
|
Tsai W.-L.; Liang P.-C.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-02-23T02:12:28Z |
Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma
|
Tsai W.-L.; Liang P.-C.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-06-27T07:00:18Z |
Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer
|
Mok T.; Ladrera G.; Srimuninnimit V.; Sriuranpong V.; CHONG-JEN YU; Thongprasert S.; Sandoval-Tan J.; Lee J.S.; Fuerte F.; Shames D.S.; Klughammer B.; Truman M.; Perez-Moreno P.; Wu Y.-L. |
| 國立交通大學 |
2014-12-08T15:30:29Z |
Tumor Marker Detection by Aptamer-Functionalized Graphene Oxide
|
Lin, Ming-Yu; Lu, Yen-Pei; Grumezescu, Alexandru Mihai; Ho, Fu Han; Kao, Ying-Hsien; Yang, Yuh-Shyong; Yang, Chih-Hui |
| 國立臺灣科技大學 |
2013 |
Tumor marker detection by aptamer-functionalized graphene oxide
|
Lin, M.-Y.;Lu, Y.-P.;Grumezescu, A.M.;Ho, F.H.;Kao, Y.-H.;Yang, Y.-S.;Yang, C.-H. |
| 義守大學 |
2013-01 |
Tumor Marker Detection by Aptamer-Functionalized Graphene Oxide
|
Ming-Yu Lin;Yen-Pei Lu;Alexandru Mihai Grumezescu;Fu Han Ho;Ying-Hsien Kao;Yuh-Shyong Yang;Chih-Hui Yang |
| 高雄醫學大學 |
1997 |
Tumor markers in head and neck cancer
|
郭文烈 |
| 臺大學術典藏 |
2020-12-02T02:36:47Z |
Tumor markers of lung cancer: carcinoembryonic antigen and TuMark.
|
PAN-CHYR YANG; Luh K.T.; Lee Y.C.; Kuo S.H.; Huang T.W. |
| 臺大學術典藏 |
2021-05-26T03:36:17Z |
Tumor markers of lung cancer: carcinoembryonic antigen and TuMark.
|
Yang P.C.; KWEN-TAY LUH; Lee Y.C.; Kuo S.H.; Huang T.W. |
| 國立臺灣大學 |
1989-09 |
Tumor Markers of Lung Cancer:Carcinoembryonic Antigen and Tumark
|
楊泮池; 郭壽雄; Luh, Kwen-Ttay; Yang, Pan-Chyr; Kuo, Sow-Hsong; Luh, Kwen-Ttay |
| 臺大學術典藏 |
2021-11-18T05:54:44Z |
Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts
|
Lee P.-J.; Ho C.-C.; Ho H.; Chen W.-J.; Lin C.-H.; Lai Y.-H.; Juan Y.-C.; Chu W.-C.; Lee J.-H.; SHENG-FANG SU; Chen H.-Y.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C.; Chen H.-W. |
| 臺大學術典藏 |
2021-11-17T06:27:11Z |
Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts
|
Lee, Pei-Jung; CHAO-CHI HO; Ho, Hao; Chen, Wan-Jiun; Lin, Chiu-Hua; Lai, Yi-Hua; Juan, Yi-Chen; Chu, Wen-Chung; Lee, Jia-Hua; Su, Sheng-Fang; Chen, Hsuan-Yu; Chen, Jeremy J W; Chang, Gee-Chen; Li, Ker-Chau; Yang, Pan-Chyr; Chen, Huei-Wen |
| 臺大學術典藏 |
2022-03-04T08:19:17Z |
Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts
|
Lee, Pei Jung; Ho, Chao Chi; Ho, Hao; Chen, Wan Jiun; Lin, Chiu Hua; Lai, Yi Hua; Juan, Yi Chen; Chu, Wen Chung; Lee, Jia Hua; Su, Sheng Fang; Chen, Hsuan Yu; Chen, Jeremy J.W.; Chang, Gee Chen; Li, Ker Chau; Yang, Pan Chyr; HUEI-WEN CHEN |
| 臺大學術典藏 |
2022-03-09T03:12:17Z |
Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts
|
Lee P.-J.; Ho C.-C.; Ho H.; Chen W.-J.; Lin C.-H.; Lai Y.-H.; Juan Y.-C.; Chu W.-C.; Lee J.-H.; Su S.-F.; Chen H.-Y.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C.; HUEI-WEN CHEN |
| 臺大學術典藏 |
2022-04-28T06:03:15Z |
Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts
|
Lee, Pei Jung; CHAO-CHI HO; Ho, Hao; Chen, Wan Jiun; Lin, Chiu Hua; Lai, Yi Hua; Juan, Yi Chen; Chu, Wen Chung; Lee, Jia Hua; SHENG-FANG SU; Chen, Hsuan Yu; Chen, Jeremy J.W.; Chang, Gee Chen; Li, Ker Chau; PAN-CHYR YANG; HUEI-WEN CHEN |
| 中山醫學大學 |
2021 |
Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts
|
Lee, PJ; Ho, CC; Ho, H; Chen, WJ; Lin, CH; Lai, YH; Juan, YC; Chu, WC; Lee, JH; Su, SF; Chen, HY; Chen, JJW; Chang, GC; Li, KC; Yang, PC; Chen, HW |
| 臺大學術典藏 |
2022-09-08T08:27:31Z |
Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts
|
Lee, Pei-Jung; Ho, Chao-Chi; Ho, Hao; Chen, Wan-Jiun; Lin, Chiu-Hua; Lai, Yi-Hua; Juan, Yi-Chen; Chu, Wen-Chung; Lee, Jia-Hua; Su, Sheng-Fang; Chen, Hsuan-Yu; Chen, Jeremy J W; Chang, Gee-Chen; Li, Ker-Chau; PAN-CHYR YANG; Chen, Huei-Wen |
| 國立臺灣科技大學 |
2016 |
Tumor Microenvironment-Responsive Nanoparticle Delivery of Chemotherapy for Enhanced Selective Cellular Uptake and Transportation within Tumor
|
Huang, W.-C;Chen, S.-H;Chiang, W.-H;Huang, C.-W;Lo, C.-L;Chern, Chern C.-S;Chiu, H.-C. |
| 國立臺灣科技大學 |
2020 |
Tumor motion tracking based on a four-dimensional computed tomography respiratory motion model driven by an ultrasound tracking technique
|
Ting, L.-L.;Chuang, H.-C.;Liao, A.-H.;Kuo, C.-C.;Yu, H.-W.;Tsai, H.-C.;Tien, D.-C.;Jeng, S.-C.;Chiou, J.-F. |
| 中山醫學大學 |
2020 |
Tumor Multifocality is a Significant Risk Factor of Urinary Bladder Recurrence after Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma: A Single-Institutional Study
|
Chen, CS; Li, JR; Wang, SS; Yang, CK; Cheng, CL; Yang, CR; Ou, YC; Ho, HC; Lin, CY; Hung, SC; Chen, CC; Wang, SC; Chiu, KY; Yang, SF |
| 臺大學術典藏 |
2020-06-17T03:01:27Z |
Tumor mutation burden and recurrent tumors in hereditary lung cancer
|
Hsu Y.-C.; Chang Y.-H.; Chang G.-C.; Ho B.-C.; Yuan S.-S.; Li Y.-C.; Zeng J.-W.; SUNG-LIANG YU; Li K.-C.; Yang P.-C.; Chen H.-Y.; Hsu Y.-C.;Chang Y.-H.;Chang G.-C.;Ho B.-C.;Yuan S.-S.;Li Y.-C.;Zeng J.-W.;Sung-Liang Yu;Li K.-C.;Yang P.-C.;Chen H.-Y. |
| 臺大學術典藏 |
2020-12-02T02:33:09Z |
Tumor mutation burden and recurrent tumors in hereditary lung cancer
|
Hsu Y.-C.; Chang Y.-H.; Chang G.-C.; Ho B.-C.; Yuan S.-S.; Li Y.-C.; Zeng J.-W.; Yu S.-L.; Li K.-C.; Pan-Chyr Yang; Chen H.-Y.; Hsu Y.-C.; PAN-CHYR YANG et al. |
| 國立臺灣大學 |
2002 |
Tumor Necrosis Factor Alpha Induces Three-Dimensional Cytomorphologic Differentiation of Human Anaplastic Thyroid Carcinoma Cells through Activation of Nuclear Factor Kappa B
|
王治元; 蔡元奮; 張天鈞; WANG, CHIH-YUAN; TSAI, YUAN-FEEN; CHANG, TIEN-CHUN |
| 臺北醫學大學 |
2002 |
Tumor necrosis factor alpha induces three-dimensional cytomorphologic differentiation of human anaplastic thyroid carcinoma cells through activation of nuclear factor kappaB.
|
鍾文彬; Wang CY; Zhong WB; Chang TC; Lai SM; Tsai YF; |
| 高雄醫學大學 |
2005 |
Tumor necrosis factor alpha promoter polymorphism at position-308 predicts hepatitis C virus response to combination therapy with high dose interferon and ribavirin
|
戴嘉言;余明隆;莊萬龍;李立柏;謝明裕;侯乃仁;張文宇 ; Dai CY;Yu ML;Chuang WL;Lee LP;Hsieh MY;Hou NJ;Chang WY |
| 中山醫學大學 |
2010-11 |
Tumor necrosis factor alpha promoter polymorphism in posttransplantation diabetes mellitus of renal transplant recipients
|
CC, Kao; JD, Lian; MC, Chou; HR, Chang; SF, Yang |
| 高雄醫學大學 |
2005 |
Tumor necrosis factor alpha promoter polymorphisms at position –308 predict hepatitis C virus response to combination therapy with high dose interferon and ribavirin
|
戴嘉言;余明隆;莊萬龍;李立柏;謝明彥;侯乃仁;王良彥;張文宇 |
| 亞洲大學 |
2005-09 |
Tumor necrosis factor alpha, CYP 17, urokinase, and interleukin 10 gene polymorphisms in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis
|
Chen HY;Huey-Yi Chen;Chen Wen-Chi;Chin-Moo Hsu;Fuu-Jen Tsai;Chang-Hai Tsai |
| 中國醫藥大學 |
2005-09 |
Tumor necrosis factor alpha, CYP 17, urokinase, and interleukin 10 gene polymorphisms in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis
|
(Chen HY); 陳慧毅(Huey-Yi Chen); 陳汶吉(Chen Wen-Chi); 許欽木(Chin-Moo Hsu); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai) |
| 中國醫藥大學 |
2005-09 |
Tumor necrosis factor alpha, CYP 17, urokinase, and interleukin 10 gene polymorphisms in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis
|
(Chen HY); 陳慧毅(Huey-Yi Chen); 陳汶吉(Chen Wen-Chi); 許欽木(Chin-Moo Hsu); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai) |
| 中國醫藥大學 |
2005 |
Tumor necrosis factor alpha, CYP 17, urokinase, and interleukin 10 gene polymorphisms in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis
|
Chen, HY; Chen, WC; Hsu, CM; Tsai, FJ; Tsai, CH |
